Teladoc
American healthcare company
TDOC NYSE
ISIN US87918A1051 SEC CIK 1477449 LEI 549300I2PVFBC9MFAC61
Follow Teladoc
Weekly email: filings, results
Revenue, last quarter
$605.1M
−3.4% vs same quarter last year
Net income
−$26.9M
+45.6% vs same quarter last year
EPS, diluted
−$0.15
+46.4% vs same quarter last year
Operating cash flow
$106.5M
+7.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.5B | −$200.3M |
| FY24 | $2.6B | −$1B |
| FY23 | $2.6B | −$220.4M |
| FY22 | $2.4B | −$13.7B |
| FY21 | $2B | −$428.8M |
| FY20 | $1.1B | −$485.1M |
| FY19 | $553.3M | −$98.9M |
| FY18 | $417.9M | −$97.1M |
| FY17 | $233.3M | −$106.8M |
| FY16 | $123.2M | −$74.2M |
| FY15 | $77.4M | −$58M |
| FY14 | $43.5M | −$17M |
| FY13 | $19.9M | −$6M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −10.4% | −7.9% |
| FY24 | - | −39.7% | −39% |
| FY23 | - | −9.6% | −8.5% |
| FY22 | 69.1% | −567.3% | −567.5% |
| FY21 | 68% | −13.1% | −21.1% |
| FY20 | 64.3% | −46.3% | −44.3% |
| FY19 | 66.7% | −14.5% | −17.9% |
| FY18 | 69.2% | −17% | −23.2% |
| FY17 | 73.6% | −32.3% | −45.8% |
| FY16 | 74% | −50.9% | −60.3% |
| FY15 | 72.8% | −72.1% | −75% |
| FY14 | 77.2% | −34.8% | −39.1% |
| FY13 | 79% | −29.5% | −30.2% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $285.5M |
| FY24 | $282.9M |
| FY23 | $338.6M |
| FY22 | $172.8M |
| FY21 | $185.5M |
| FY20 | −$57.5M |
| FY19 | $26.4M |
| FY18 | −$8.9M |
| FY17 | −$37.1M |
| FY16 | −$54M |
| FY15 | −$53.5M |
| FY14 | −$12.4M |
| FY13 | −$6.3M |
| FY12 | - |
- Teladoc
- Healthcare median
Show the numbers
| Year | Teladoc | Healthcare median |
|---|---|---|
| FY25 | −7.9% | −30.6% |
| FY24 | −39% | −47% |
| FY23 | −8.5% | −58% |
| FY22 | −567.5% | −80.4% |
| FY21 | −21.1% | −71.9% |
| FY20 | −44.3% | −62.2% |
| FY19 | −17.9% | −46.3% |
| FY18 | −23.2% | −49.6% |
| FY17 | −45.8% | −45.9% |
| FY16 | −60.3% | −36% |
| FY15 | −75% | −38.4% |
| FY14 | −39.1% | −35.5% |
| FY13 | −30.2% | −37.1% |
| FY12 | - | −29.1% |